Rhumbline Advisers Ovid Therapeutics Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 68,723 shares of OVID stock, worth $70,784. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,723

Previous 69,733 1.45%

Holding current value

$70,784

Previous $53,000 52.83%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$0.75 - $1.3 $757 - $1,313	-1,010 Reduced 1.45%	68,723 $81,000
Q2 2024 Aug 01, 2024	SELL	$0.7 - $3.34 $8,995 - $42,922	-12,851 Reduced 15.56%	69,733 $53,000
Q1 2024 May 09, 2024	BUY	$2.72 - $4.04 $7,936 - $11,788	2,918 Added 3.66%	82,584 $251,000
Q4 2023 Feb 08, 2024	SELL	$2.98 - $3.78 $9,312 - $11,812	-3,125 Reduced 3.77%	79,666 $256,000
Q3 2023 Nov 09, 2023	BUY	$3.23 - $3.97 $12,994 - $15,971	4,023 Added 5.11%	82,791 $317,000
Q2 2023 Aug 08, 2023	BUY	$2.53 - $3.89 $199,283 - $306,407	78,768 New	78,768 $258,000
Q2 2021 Aug 05, 2021	SELL	$3.3 - $4.49 $161,667 - $219,965	-48,990 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$2.42 - $4.47 $1,645 - $3,039	-680 Reduced 1.37%	48,990 $197,000
Q4 2020 Feb 10, 2021	BUY	$2.28 - $6.84 $7,729 - $23,187	3,390 Added 7.32%	49,670 $115,000
Q3 2020 Nov 12, 2020	SELL	$5.39 - $8.24 $10,483 - $16,026	-1,945 Reduced 4.03%	46,280 $266,000
Q2 2020 Aug 13, 2020	BUY	$2.67 - $7.91 $128,760 - $381,459	48,225 New	48,225 $355,000
Q2 2019 Aug 14, 2019	SELL	$1.59 - $2.14 $27,045 - $36,401	-17,010 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$1.77 - $3.56 $812 - $1,634	459 Added 2.77%	17,010 $30,000
Q4 2018 Jan 31, 2019	BUY	$2.42 - $6.6 $12,850 - $35,046	5,310 Added 47.24%	16,551 $40,000
Q3 2018 Nov 07, 2018	SELL	$5.6 - $11.0 $3,220 - $6,325	-575 Reduced 4.87%	11,241 $64,000
Q2 2018 Aug 06, 2018	BUY	$6.16 - $10.14 $72,786 - $119,814	11,816 New	11,816 $92,000

Others Institutions Holding OVID

# of Institutions

Shares Held

39M

Call Options Held

37.4K

Put Options Held

500

View Full List

About Ovid Therapeutics Inc.

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $72.5M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

More about OVID

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Ovid Therapeutics Inc. Transaction History